Electroencephalographic features of convulsive epilepsy in Africa: A multicentre study of prevalence, pattern and associated factors by Kariuki, SM et al.
Clinical Neurophysiology 127 (2016) 1099–1107Contents lists available at ScienceDirect
Clinical Neurophysiology
journal homepage: www.elsevier .com/locate /c l inphElectroencephalographic features of convulsive epilepsy in Africa: A
multicentre study of prevalence, pattern and associated factorshttp://dx.doi.org/10.1016/j.clinph.2015.07.033
1388-2457/ 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑
Corresponding author at: P.O. Box 230, 80108 Kilifi, Kenya.
E-mail address: skariuki@kemri-wellcome.org (S.M. Kariuki).
1 See Appendix A for The SEEDS investigators.Symon M. Kariuki a,b,⇑, Steven White c, Eddie Chengo a,d, Ryan G. Wagner e,f, Kenneth A. Ae-Ngibise g,
Angelina Kakooza-Mwesige h,i, Honorati Masanja j, Anthony K. Ngugi k, Josemir W. Sander l,m,
Brian G. Neville n, Charles R. Newton a,o, on behalf of SEEDS investigators,1
aKEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, Kenya
bNuffield Department of Medicine, University of Oxford, OX3 7BN Oxford, UK
cDepartment of Clinical Neurophysiology, Great Ormond Street Hospital for Children, WC1N 3JH London, UK
d Foundation for People with Epilepsy, 80200 Malindi, Kenya
eMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, P.O. Box 2
Cornhoek 1360, Johannesburg, South Africa
f Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå University, 901 85 Umeå, Sweden
gKintampo Health and Demographic Surveillance System, P.O. Box 200, Kintampo, Ghana
h Iganga-Mayuge Health and Demographic Surveillance System, P.O. Box 111, Iganga, Uganda
iDepartment of Paediatrics and Child Health, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda
j Ifakara Health and Demographic Surveillance System, P.O. Box 78373, Ifakara, Tanzania
k Population Health Sciences/Research Support Unit, Faculty of Health Sciences, Aga Khan University (East Africa), Aga Khan Hospital Building, Third Parklands Ave., P.O. Box 30270,
Nairobi, Kenya
lNIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, Queen Square, London WC1N 3BG and Epilepsy Society, Chalfont St. Peter SL9 8ES,
Bucks, UK
m Stichting Epilepsie Instellingen Nederland-SEIN, 2103SW Heemstede, Netherlands
nNeurosciences Unit, UCL Institute of Child Health, WC1E 6BT London, UK
oDepartment of Psychiatry, University of Oxford, OX3 7JX Oxford, UK
a r t i c l e i n f oArticle history:
Accepted 28 July 2015
Available online 20 August 2015
Keywords:
Electroencephalographic features
Active convulsive epilepsy
Risk factors
Africah i g h l i g h t s
 Electroencephalographic abnormalities are common in Africans with epilepsy, with an adjusted
prevalence of 2.7 (95% confidence interval, 2.5–2.9) per 1000 population.
 Electroencephalographic abnormalities are associated with preventable factors such as adverse peri-
natal events and frequent seizures.
 Electroencephalography is helpful in identifying focal epilepsy in Africa, where timing of focal aetiolo-
gies is problematic and there is a lack of neuroimaging services.
a b s t r a c t
Objective: We investigated the prevalence and pattern of electroencephalographic (EEG) features of epi-
lepsy and the associated factors in Africans with active convulsive epilepsy (ACE).
Methods: We characterized electroencephalographic features and determined associated factors in a
sample of people with ACE in five African sites. Mixed-effects modified Poisson regression model was
used to determine factors associated with abnormal EEGs.
Results: Recordings were performed on 1426 people of whom 751 (53%) had abnormal EEGs, being an
adjusted prevalence of 2.7 (95% confidence interval (95% CI), 2.5–2.9) per 1000. 52% of the abnormal
EEG had focal features (75% with temporal lobe involvement). The frequency and pattern of changes dif-
fered with site. Abnormal EEGs were associated with adverse perinatal events (risk ratio (RR) = 1.19 (95%
CI, 1.07–1.33)), cognitive impairments (RR = 1.50 (95% CI, 1.30–1.73)), use of anti-epileptic drugs
(RR = 1.25 (95% CI, 1.05–1.49)), focal seizures (RR = 1.09 (95% CI, 1.00–1.19)) and seizure frequency
(RR = 1.18 (95% CI, 1.10–1.26) for daily seizures; RR = 1.22 (95% CI, 1.10–1.35) for weekly seizures and
1100 S.M. Kariuki et al. / Clinical Neurophysiology 127 (2016) 1099–1107RR = 1.15 (95% CI, 1.03–1.28) for monthly seizures)).
Conclusions: EEG abnormalities are common in Africans with epilepsy and are associated with pre-
ventable risk factors.
Significance: EEG is helpful in identifying focal epilepsy in Africa, where timing of focal aetiologies is
problematic and there is a lack of neuroimaging services.
 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epilepsy in Africa is associated with significant morbidity and
mortality and a large treatment gap (Newton and Garcia, 2012).
Focal features defined by seizure semiology and neurological defi-
cits are common in people with epilepsy from Africa and may be
related to perinatal complications, head injuries, and central ner-
vous system infections (Kariuki et al., 2014). Active convulsive epi-
lepsy (ACE) in Africa is associated with childhood onset in 60% of
cases, convulsive status epilepticus in about 30%, non-adherence
to treatment in 60% and psychosocial problems such as being sin-
gle in over 60% (Mbuba et al., 2012; Kariuki et al., 2015b). The pat-
tern of neurophysiological features and their association with
clinical and psychosocial factors have not been fully ascertained
in low and middle-income countries.
Electroencephalography (EEG) is a well-established investiga-
tion for evaluating epilepsy and is useful in confirming the diagno-
sis, classifying seizures, and identifying epilepsy syndromes and
epileptogenic zones (Fish and Spencer, 1995). The proportion of
abnormal EEGs varies between epilepsy syndromes and may differ
between hospital- and community-based samples (Binnie and
Stefan, 2003). In a broad sample of people with different types of
epilepsy, the yield of interictal epileptiform activity in a single
30-min awake EEG recording is up to 50%, although there is sub-
stantial variability between individuals (Cockerell et al., 1996;
Binnie and Stefan, 2003). The diagnostic yield of EEG can be
improved through increased recording time, serial recordings,
sleep and activation procedures such as hyperventilation and pho-
tic stimulation (Nuwer, 2012).
In Kenya, the EEG was abnormal in 41% of people with ACE
(Munyoki et al., 2010), but this study did not relate the EEG find-
ings to medical and psychosocial factors and cannot be extrapo-
lated to other African settings, where clinical features and risk
factors of epilepsy may differ (Ngugi et al., 2013; Kariuki et al.,
2014). EEG services are becoming more readily available in Africa
and are more common than neuroimaging (Wilmshurst et al.,
2011). Studies characterizing the patterns of EEG abnormalities
and their clinical and psychosocial correlates may contribute to
improving the evaluation and management of epilepsy.
We performed EEGs on people with ACE in five African sites to
determine prevalence and patterns of abnormality and to charac-
terize the clinical and psychosocial correlates. We further deter-
mined whether these factors differed across these sites.2. Methods
2.1. Population and sites
We performed EEG on people with ACE identified from a
previous epidemiological survey conducted across five sites in
Africa, (Agincourt in South Africa; Ifakara in Tanzania; Iganga in
Uganda; Kilifi in Kenya and Kintampo in Ghana) (Ngugi et al.,
2013). Specific details for the participating sites are available at:
http://www.indepth-network.org/index.php?option=com_content&
task=view&id=753&Itemid=635. The prevalence of ACE ranged from7 to 15 per 1000 across the five sites and was associated with
exposure to multiple parasites (Kamuyu et al., 2014).
2.2. Investigations and procedures
Electroencephalography was performed using a 16 channel dig-
ital recording system (Grass Technologies, Warwick, RI, USA) with
electrode placement according to the international 10–20 system
(Japer, 1958). All hyperventilated for 3 min and had photic stimu-
lation (Binnie, 2003). EEGs were reported by one physician (EC),
using a protocol developed under the guidance of an experienced
neurophysiologist (SW). This protocol followed standard defini-
tions of the EEG features commonly assessed in clinical practice
(Binnie, 2003; Binnie and Stefan, 2003). Briefly, the report com-
mented on the general background activity classified as normal
or abnormal if there was a mild, moderate or severe excess of gen-
eralized slow activity. Significant background asymmetries
between the hemispheres and non-epileptiform focal features
(mainly focal theta and slow activity) were coded. Interictal epilep-
tiform discharges (IEDs) were identified. These were defined as
sharp waves, spike discharges, spike and wave complexes, poly-
spike and wave bursts. IEDs were classified as generalized (diffuse
abnormal EEG pattern involving the entire brain), focal (localized
abnormal EEG pattern involving a region of the brain) or multifocal
(involving 3 or more discrete brain regions). Abnormalities during
hyperventilation (focal or asymmetric slowing; focal or general-
ized epileptiform activity) and evidence of photosensitivity (pho-
toparoxysmal responses) were noted. An EEG was categorized as
abnormal if there was evidence of an abnormal background, focal
changes, interictal epileptiform activity or an abnormal response
to either of the activation procedures (hyperventilation and photic
stimulation).
A sample of EEGs recordings and reports were checked for accu-
racy and consistency by SW. A clinician recorded use of anti-
epileptic drugs (AEDs) and history of febrile or non-febrile seizures
in the family.
2.3. Definition of terms
Epilepsy, defined as P2 unprovoked seizures (ILAE, 1993), was
classified as active if seizures had occurred in the previous
12 months. Seizures were classified as focal, generalized, or other
using a classification system devised for epidemiologic studies
(Thurman et al., 2011). Seizure frequency was categorized into
daily (at least one each day; coded 3), weekly (at least one a week;
coded 2), monthly (at least one a month; coded 1), and yearly (at
least one a year; coded 0). Status epilepticus was defined as a his-
tory of seizures lasting 30 min or more, while for those without
watches, culturally appropriate events such as boiling a pot of
maize were used to estimate time as defined previously (Kariuki
et al., 2015b). Status epilepticus was considered febrile if it
occurred with a febrile illness. Children were defined as those
<18 years. A clinician assessed cognitive status by asking standard-
ized questions about awareness of place, person and time. Deter-
mination of malnutrition was described previously (Kariuki et al.,
2014). Acute encephalopathy was defined as a history of admission
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perinatal events were defined in those 618 years as a history of
delays in crying, breathing and/or breastfeeding at birth.2.4. Statistical analysis
We performed statistical analysis with STATA version 13.1
(Stata Corp, Texas, USA). Prevalence of EEG abnormalities was
determined by dividing abnormalities over the surveyed popula-
tion expressed per 1000 and accounted for the sensitivity of the
three-stage screening methodology. The three-stage methodology
involved asking of two seizure questions during a routine door-
to-door census in the study area in stage-one, collection of detailed
seizure information in those with a history of seizures in stage-
two, diagnosis of epilepsy by clinicians in those whose seizure
details suggested a possibility of repetitive unprovoked seizures
in stage-three (Ngugi et al., 2013). Chi-square and Fisher exact
(for infrequent measures) tests compared proportions between
groups. Student’s t-test and Mann–Whitney U-test (non-
parametric) compared continuous variables such as age. We used
modified Poisson regression to compute site-specific relative risks
or risk ratios for the associations between EEG features and clinical
features and/or psychosocial consequences, with associations
reaching a p-value of 0.25 entered into a multivariable model
adjusted for age and sex. For associations pooled across all five
sites, mixed-effects modified Poisson regression model with a ran-
dom intercept for site was used since the investigated variables
and other unmeasured factors may differ across sites. The four cat-
egories of seizure frequency (1–4) were considered as non-linear in
the fitted models and thus individual risk ratio (RR) for each cate-
gory were provided compared with the baseline category. We
reported RR since they are more easily interpreted in common con-
ditions with a prevalence >10% (Zou, 2004).2.5. Ethical approval and data security
Ethical approval for this study was granted by the Kenyan Eth-
ical Review Committee and all study participants provided a
written-informed consent. Data were anonymised and secured at
the research servers of the KEMRI-Wellcome Trust Research
Programme.Fig. 1. Derivation of study sample across five sites in Africa. Electroencephalographic inv
the five sites in Africa.3. Results
3.1. Description of participants
EEG was performed on 1426 (66%) of 2170 people with ACE
whose clinical features were previously described (Fig. 1). Of the
1426 with an EEG, 746 (52%) were males and 679 (48%) were chil-
dren. Most socio-demographic characteristics, medical history and
seizure factors of the 1426 participants with EEG data differed
across sites (Tables 1 and 2). There were no differences in features
of severe epilepsy between those who provided an EEG sample and
those who did not: convulsive status epilepticus (24% vs. 26%,
p = 0.577), frequent seizures (20% vs. 19%. p = 0.540) and AED use
(37% vs. 35%, p = 0.372).
3.2. Prevalence of EEG abnormalities
EEG abnormalities were present in 751/1426 (53%) in all sites,
being highest in Kilifi (293/508 (58%)) and lowest in Iganga
(61/147 (42%)) (Table 1–3). EEG abnormalities were similar in
males and females (386/746 (52%) vs. 365/680 (54%); p = 0.465).
EEG abnormalities were more frequent in children than adults
(398/679 (59%) vs. 353/747 (47%); p < 0.0001).
The overall adjusted prevalence of EEG abnormalities per 1000
population was 2.7 (95% CI, 2.5–2.9), being highest in Agincourt
and lowest in Iganga (Fig. 2). Focal features formed over half of
the prevalence and were most common in Agincourt and lowest
in Iganga (Fig. 2). The prevalence of EEG abnormalities differed
with age group, increasing steadily with age and then declining
after age 28 years. Prevalence of focal EEG features did not change
with age (p = 0.269).
3.3. Pattern and distribution of EEG abnormalities
3.3.1. General pattern
Of the 751 subjects with EEG abnormalities, 390 (52%) had focal
features, which were commonest in Agincourt (106/111 (96%)) and
the occurrence differed with site (Table 3). Most of these focal fea-
tures had temporal lobe involvement (292/390 (75%)). IEDs were
present in 473/751 (63%) of those with abnormal EEG and tempo-
ral lobe involvement was common (375/473 (79%)). Multifocal IED
were observed in 181/751 (24%) of those with abnormal EEGs,estigations were done in over half of those with active convulsive epilepsy across all
Table 1
Sociodemographic characteristics, and medical comorbidities of active convulsive epilepsy in those with electroencephalograms.
Features Agincourt Ifakara Iganga Kilifi Kintampo All sites
Normal EEG
(N = 103)
Abnormal EEG
(N = 111)
Normal EEG
(N = 95)
Abnormal EEG
(N = 120)
Normal EEG
(N = 86)
Abnormal
EEG (N = 61)
Normal EEG
(N = 215)
Abnormal EEG
(N = 293)
Normal EEG
(N = 176)
Abnormal EEG
(N = 166)
Total normal
(N = 675)
Total
abnormal
(N = 751)
Age in years: median
(IQR)
36 (19–49) 27 (17–40) 25 (14–36) 16 (11–28) 11 (5–17) 13 (6–21) 19 (10–31) 16 (10–26) 23 (16–33) 18 (13–25) 21 (13–35) 18 (11–27)
Males 55 (53%) 58 (52%) 45 (47%) 50 (42%) 45 (52%) 31 (51%) 119 (55%) 153 (52%) 96 (55%) 94 (57%) 360 (53%) 386 (51%)
Perinatal
complications
0/24 (0%) 5/33 (15%) 2/35 (6%) 7/68 (10%) 5/67 (8%) 0/41 (0%) 4/102 (4%) 14/171 (8%) 12/57 (21%) 30/88 (34%) 23/285 (8%) 56/401 (14%)
Abnormal pregnancy 1/15 (7%) 0/29 (0%) 5/34 (15%) 6/34 (9%) 9/66 (14%) 1/41 (2%) 18/100 (18%) 40/164 (24%) 11/48 (23%) 10/74 (14%) 44/263 (17%) 57/371 (15%)
Age at onset of
seizures: median
(IQR)
21 (6–36) 13 (4–30) 15 (3–25) 5 (2–13) 2 (1–5) 2 (1–7) 4 (1–18) 3 (1–10) 11 (4–21) 7 (2–13) 8 (2–21) 4 (1–12)
Family history of
seizures
8 (8%) 10 (9%) 28 (29%) 38 (32%) 23 (27%) 17 (28%) 56 (26%) 84 (29%) 50 (28%) 53 (32%) 165 (24%) 202 (27%)
Family history of
febrile seizures
1 (1%) 3 (3%) 2 (2%) 2 (2%) 15 (17%) 10 (16%) 26 (12%) 42 (14%) 12 (7%) 13 (8%) 56 (8%) 70 (9%)
Acute encephalopathy 2 (2%) 2 (2%) 0 (0%) 1 (1%) 17 (20%) 6 (10%) 28 (13%) 81 (28%) 2 (1%) 3 (2%) 49 (7%) 93 (12%)
Comorbidities of active convulsive epilepsy
Malnutrition 11 (11%) 12 (11%) 9 (9%) 14 (12%) 17 (20%) 12 (20%) 34 (16%) 51 (17%) 15 (9%) 18 (11%) 86 (13%) 107 (14%)
Neurological deficits 14 (14%) 27 (24%) 2 (2%) 20 (17%) 4 (5%) 17 (28%) 21 (10%) 64 (22%) 7 (4%) 32 (19%) 48 (7%) 160 (21%)
Cognitive impairment 18 (17%) 39 (35%) 4 (4%) 23 (19%) 5 (6%) 16 (26%) 26 (12%) 102 (35%) 28 (16%) 62 (37%) 81 (12%) 242 (32%)
Head injuries 6 (6%) 11/110 (10%) 6/92 (7%) 3/119 (3%) 5/85 (6%) 3/60 (5%) 31/210 (15%) 35/288 (12%) 38 (22%) 49/163 (30%) 86/666 (13%) 101/740 (14%)
Psychosocial factors and outcomes in active convulsive epilepsy
Burns 15 (15%) 15 (14%) 16 (17%) 17 (14%) 5 (6%) 5 (8%) 31 (14%) 61 (21%) 24 (14%) 29 (17%) 91 (14%) 127 (17%)
Unschooled 23 (22%) 32 (29%) 22 (23%) 65 (54%) 33 (38%) 29 (48%) 89 (41%) 145 (49%) 69 (39%) 67 (40%) 236 (35%) 338 (45%)
Unemployed adults 71/79 (90%) 75/80 (94%) 10/61 (16%) 24/52 (46%) 17/20 (85%) 15/20 (75%) 69/114 (61%) 74/122 (61%) 42/120 (35%) 46/79 (58%) 209/394
(53%)
234/353 (66%)
Unmarried adults 50/79 (63%) 64/80 (80%) 36/61 (59%) 37/52 (71%) 13/20 (65%) 17/20 (85%) 67/114 (59%) 90/122 (74%) 81/120 (68%) 63/79 (80%) 247/394
(63%)
271/353 (77%)
IQR = interquartile range; EEG = electroencephalography.
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Table 2
Seizure types, status epilepticus and treatment of convulsive active epilepsy in those with electroencephalograms.
Features Agincourt Iganga Ifakara Kilifi Kintampo Total Total
Normal EEG
(N = 103)
Abnormal EEG
(N = 111)
Normal EEG
(N = 95)
Abnormal EEG
(N = 120)
Normal EEG
(N = 86)
Abnormal
EEG (N = 61)
Normal EEG
(N = 215)
Abnormal EEG
(N = 293)
Normal EEG
(N = 176)
Abnormal EEG
(N = 166)
Normal EEG
(N = 675)
Abnormal EEG
(N = 751)
All generalized
seizures
55 (53%) 66 (59%) 54 (57%) 59 (49%) 57 (66%) 45 (74%) 60 (28%) 103 (35%) 118 (67%) 104 (63%) 344 (51%) 377 (50%)
Generalized tonic-
clonic seizures
45 (44%) 60 (54%) 47 (50%) 51 (43%) 51 (59%) 43 (70%) 52 (24%) 85 (29%) 110 (63%) 97 (58%) 305 (45%) 336 (45%)
Generalized other
convulsive seizures
5 (5%) 4 (4%) 0 (0%) 1 (1%) 2 (2%) 1 (2%) 8 (4%) 5 (2%) 5 (3%) 4 (2%) 20 (3%) 15 (2%)
Generalized absence
seizures
8 (8%) 12 (11%) 2 (2%) 3 (3%) 2 (2%) 2 (3%) 2 (1%) 17 (6%) 5 (3%) 12 (7%) 19 (3%) 46 (6%)
Generalized
unspecified
seizures
2 (2%) 1 (1%) 7 (7%) 10 (8%) 3 (3%) 1 (2%) 0 (0%) 3 (1%) 2 (1%) 3 (2%) 14 (2%) 18 (2%)
Focal seizures
All focal seizures 46 (45%) 46 (41%) 23 (24%) 42 (35%) 26 (30%) 19 (31%) 142 (66%) 201 (69%) 58 (33%) 66 (40%) 295 (44%) 374 (50%)
Focal with
generalization
46 (45%) 42 (38%) 16 (17%) 33 (28%) 21 (24%) 13 (21%) 64 (30%) 101 (34%) 47 (27%) 57 (34%) 194 (29%) 246 (33%)
Focal convulsive
seizures
1 (1%) 2 (2%) 2 (2%) 4 (3%) 1 (1%) 1 (2%) 48 (22%) 72 (25%) 2 (1%) 1 (1%) 54 (8%) 80 (11%)
Focal dyscognitive
seizures
1 (1%) 7 (6%) 1 (1%) 6 (5%) 3 (3%) 6 (10%) 26 (12%) 39 (13%) 11 (6%) 11 (7%) 42 (6%) 69 (9%)
Focal sensory seizures 0 (0%) 0 (0%) 1 (1%) 1 (1%) 0 (0%) 0 (0%) 5 (2%) 2 (1%) 0 (0%) 1 (1%) 6 (1%) 4 (1%)
Focal unspecified
seizures
0 (0%) 0 (0%) 3 (3%) 4 (3%) 2 (2%) 0 (0%) 9 (4%) 11 (4%) 0 (0%) 0 (0%) 14 (2%) 11 (2%)
Other unspecified
seizures
1 (1%) 1 (1%) 0 (0%) 1 (1%) 0 (0%) 0 (0%) 3 (1%) 1 (<1%) 0 (0%) 0 (0%) 4 (1%) 3 (<1%)
Other convulsive
seizures
0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 0 (0%) 5 (2%) 6 (2%) 0 (0%) 4 (2%) 6 (1%) 10 (1%)
Impaired
consciousness
0 (0%) 0 (0%) 0 (0%) 1 (1%) 0 (0%) 0 (0%) 0 (0%) 1 (<1%) 0 (0%) 0 (0%) 0 (0%) 2 (<1%)
Status epilepticus and use of AEDs
Status epilepticus 29/85 (34%) 24/89 (27%) 2/70 (3%) 4/87 (5%) 37/79 (47%) 18/59 (31%) 60/200 (30%) 110/281 (39%) 14/169 (8%) 14/158 (9%) 142/603
(24%)
170/674 (25%)
Febrile status
epilepticus
2/85 (2%) 6/89 (7%) 0/71 (0%) 1/88 (1%) 17/79 (22%) 7/59 (12%) 39/201 (19%) 88/283 (31%) 2/159 (1%) 3/147 (2%) 60/595 (10%) 105/666 (16%)
AEDs use 57 (55%) 69 (62%) 38 (40%) 68 (57%) 15 (17%) 18 (30%) 70 (33%) 146 (50%) 24 (14%) 21 (13%) 204 (30%) 322 (43%)
AEDs = anti-epileptic drugs; EEG = electroencephalography.
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(58%) of those with abnormal EEGs.
3.3.2. Distribution across epilepsy and medical factors
EEG abnormalities were more frequent in those with a history
of adverse perinatal events (aged 6 18 years) (56/79 (71%) vs.
345/607 (57%); p = 0.017; Table 1) and acute encephalopathy
(93/142 (65%) vs. 658/1284 (51%); p = 0.001) compared to those
without such histories. Abnormalities were commoner in focal sei-
zures than those without these seizures (374/669 (56%) vs.
377/757 (50%); p = 0.021) and in those with neurological deficits
than in those without (160/208 (77%) vs. 591/1218 (49%);
p < 0.0001).
Abnormalities were similar in those with convulsive status
epilepticus compared to those without (p = 0.487) (Table 2), but
were more common in those with a history of febrile convulsive
status epilepticus compared to those without convulsive epilepti-
cus status (105/165 (64%) vs. 561/1096 (51%); p = 0.003) and were
associated with seizure frequency (univariate RR = 1.64 (95% CI,Table 3
Distribution of abnormal electroencephalographic features across the five African sites.
Features Agincourt
(N = 111)
Ifakara
(N = 120)
Igan
(N =
Focal EEG features 106 (95%) 72 (60%) 23
Interictal epileptiform discharges 58 (52%) 79 (66%) 36
Multifocal epileptiform discharges 26 (23%) 36 (30%) 19
Generalized epileptiform discharges 5 (5%) 16 (13%) 9 (1
Other EEG features 87 (78%) 83 (69%) 28
Hyperventilation 20/106 (19%) 25/98 (26%) 5/3
Photosensitivity 6/108 (6%) 15/115 (13%) 1/1
EEG = electroencephalography; The total population (N) is the abnormal EEG features in
Fig. 2. Prevalence of electroencephalographic features in active convulsive epilepsy in Afr
being highest in Kintampo; and increased with age up to 28 years then declined.1.46–1.83) for daily seizures; RR = 1.77 (95% CI, 1.47–2.14) for
weekly seizures and RR = 1.44 (95% CI, 1.24–1.67) for monthly sei-
zures). Abnormalities were observed more often in those with self-
reported use of AED compared to those without (322/526 (61%) vs.
429/900 (48%); p < 0.0001) (Table 2).3.3.3. Focal EEG features and epilepsy and medical factors
Focal features were associated with an earlier onset of seizures
(univariate RR = 0.99 (95% CI, 0.98–0.99); p < 0.0001) and increased
seizure frequency (univariate RR = 1.731 (95% CI, 1.43–2.10) for
daily seizures; RR = 2.01 (95% CI, 1.54–2.62 for weekly seizures
and RR = 1.61 (95% CI, 1.25–2.09) for monthly seizures), among
those with abnormal EEG. Focal changes were similar in those with
and without a history of adverse perinatal events (28/55 (51%) vs.
178/344 (52%); p = 0.908) and acute encephalopathy (40/93 (43%)
vs. 350/658 (53%); p = 0.076). Focal features occurred in 196/375
(52%) of those with generalized seizure semiology and abnormal
EEG.ga
61)
Kilifi
(N = 293)
Kintampo
(N = 166)
All sites
(N = 751)
p-value
(38%) 115 (39%) 74 (45%) 390 (52%) <0.0001
(59%) 170 (58%) 130 (78%) 473 (63%) <0.0001
(31%) 65 (22%) 35 (21%) 181 (24%) 0.250
5%) 39 (13%) 46 (28%) 115 (15%) <0.0001
(46%) 190 (65%) 47 (28%) 435 (58%) <0.0001
0 (17%) 30/235 (13%) 41/148 (28%) 12/617 (20%) 0.004
0 (10%) 20/280 (7%) 0/4 (0%) 42/517 (8%) 0.245
each site. The features are not mutually exclusive.
ica by focal features and site. The prevalence was heterogeneous across the five sites
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Hyperventilation provoked abnormalities in 121/617 (20%) of
abnormal EEGs, this being most common in Kintampo (41/148
(28%)), with significant differences across the five sites (Table 3).
Abnormal hyperventilation responses were associated with the
age (univariate RR = 0.0.97 (95% CI, 0.0.96–0.98); p < 0.0001) and
were significantly greater in those with generalized IEDs than
those without (47/79 (59%) vs. 80/538 (15%); p < 0.0001). Photo-
sensitivity was seen in 42/517 (8%) with abnormal EEGs being
most common in Ifakara (15/115 (13%)), and was similar across
the sites. Photosensitivity was significantly commoner in children
than adults (30/264 (11%) vs. 12/253 (5%); p = 0.006) and in those
with multifocal IEDs compared to those without (31/120 (26%) vs.
11/397 (3%); p < 0.0001).3.4. Factors associated with EEG abnormalities
Several factors were associated with abnormal EEG features in
the univariate analysis (Table 4). After including variables with a
p-value of 60.25 in a multivariable model, the following were
independently associated with abnormal EEGs for all participants
from the five sites combined: adverse perinatal events (RR = 1.19
(95% CI, 1.07–1.33)), cognitive impairments (1.50 (95% CI, 1.30–
1.73)), use of AEDs (RR = 1.25 (95% CI, 1.05–1.49)), focal seizures
(RR = 1.10 (95% CI = 1.00–1.19)) and seizure frequency (RR = 1.18
(95% CI, 1.10–1.26) for daily seizures; RR = 1.22 (95% CI, 1.10–
1.35) for weekly seizures and RR = 1.15 (95% CI, 1.03–1.28) for
monthly seizures). Factors independently associated with abnor-
mal EEGs within the sites are shown in Table 5. None was signifi-
cant in every one of the five sites.4. Discussion
This study suggests that the prevalence of EEG abnormalities in
Africans with ACE is high; particularly in children and that they dif-Table 4
Univariate analysis of the association of abnormal electroencephalographic features with
Features Agincourt Ifakara Iga
RR (95% CI) RR (95% CI) RR
Age 0.99 (0.98–0.99) 0.99 (0.98–1.00) 1.0
Male sex 0.97 (0.75–1.27) 0.90 (0.70–1.16) 0.9
Family history of all seizures 1.08 (0.70–1.67) 1.05 (0.81–1.35) 1.0
Family history of febrile seizures 1.46 (0.81–2.61) 0.89 (0.33–2.41) 0.9
Perinatal abnormalities 1.86 (1.44–2.40) 1.20 (0.82–1.76) –
Abnormal pregnancy – 0.82 (0.47–1.44) 0.2
Head injuries 1.28 (0.88–1.87) 0.58 (0.23–1.48) 0.9
Age at onset of seizures 0.99 (0.98–1.00) 0.97 (0.95–0.99) 0.9
Focal seizures 0.94 (0.72–1.22) 1.24 (0.98–1.58) 1.0
Generalized seizures 1.13 (0.86–1.47) 0.87 (0.69–1.11) 1.2
Other convulsive seizures – – –
Impaired consciousness – 1.81 (1.60–2.05) –
Seizure frequency: dailya 1.47 (0.93–2.31) 1.66 (1.14–2..42) 2.3
Seizure frequency: weeklya 1.83 (1.24–2.69) 1.03 (0.53–2.02) 2.5
Seizure frequency: monthlya 1.26 (0.94–1.69) 1.25 (0.87–1.79) 1.7
Status epilepticus 0.84 (0.60–1.18) 1.21 (0.68–2.18) 0.6
Febrile status epilepticus 1.05 (0.90–1.22) 1.82 (1.58–2.09) 0.6
Neurological deficits 1.36 (1.04–1.78) 1.75 (1.45–2.12) 2.3
Cognitive impairments 1.49 (1.17–1.91) 1.65 (1.34–2.04) 2.1
Malnutrition 1.01 (0.66–1.53) 1.10 (0.78–1.57) 0.9
AED use 1.15 (0.88–1.50) 1.34 (1.05–1.72) 1.4
Burns 0.96 (0.65–1.41) 0.91 (0.64–1.34) 1.2
Unmarried 1.23 (0.91–1.68) 1.09 (0.86–1.38) 1.3
Unemployed 0.88 (0.66–1.15) 1.33 (1.03–1.72) 1.1
Unschooled 1.17 (0.89–1.54) 1.74 (1.38–2.20) 1.2
RR = risk ratio; CI = confidence interval; AEDs-anti-epileptic drugs. Associations reach
Associations marked as a dash (–) represents variables that were too few to run the mo
a The three categories of seizure frequency are compared with the baseline categoryfer significantly between sites. EEG abnormalities were associated
with perinatal complications, neurocognitive impairments and epi-
lepsy related factors such as AED use and seizure frequency. In the
within site analysis, none of these factors was associated with
abnormal EEG across all the five sites, with only AED use appearing
significant in three sites.
4.1. Prevalence of EEG abnormalities
The prevalence of EEG abnormalities is higher than in a previ-
ous Kenyan study (Munyoki et al., 2010), suggesting that estimates
from one site cannot be extrapolated across Africa. The estimates
represent an absolute minimum since non-convulsive epilepsy
was not assessed, which may increase the prevalence of observed
EEG abnormalities (Zehtabchi et al., 2013). Only single routine
EEG recordings were performed, which will be expected to have
a lower yield of abnormalities than serial or sleep EEGs (Nuwer,
2012). It was observed that a few patients had EEG performed
while drowsy or in light sleep which may have improved the yield
(but this was not systematically documented during the study).
The heterogeneity in prevalence across the sites may be related
to differences in the aetiology, e.g. falciparum malaria in Kilifi
and Iganga and head injuries in Agincourt, and epilepsy factors
reported previously (Kariuki et al., 2014). All recordings from the
five sites were rated by one individual with expertise in EEG and
epilepsy, following a standardized protocol. Over half of people
with abnormal EEG in ACE in this study may benefit from
improved diagnosis and management, although EEG are not rou-
tinely performed in Africans hospitalized with epilepsy (Kariuki
et al., 2015a).
4.2. Clinical utility of EEG
The EEG may help in classifying epilepsy as focal or generalized
(King et al., 1998). In our sample about 50% of people with abnor-
mal EEG for whom generalized seizure semiology was described inclinical features and psychosocial factors of epilepsy.
nga Kilifi Kintampo All sites
(95%) RR (95%) RR (95%) RR (95% CI)
0 (0.98–1.02) 0.99 (0.98–0.99) 0.97 (0.94–0.98) 0.99 (0.98–0.99)
7 (0.67–1.42) 0.95 (0.82–1.10) 1.04 (0.84–1.30) 0.96 (0.92–1.01)
3 (0.67–1.58) 1.06 (0.90–1.37) 1.09 (0.86–1.37) 1.06 (1.05–1.07)
6 (0.57–1.62) 1.08 (0.88–1.33) 1.08 (0.73–1.60) 1.05 (0.95–1.17)
1.26 (0.97–1.65) 1.27 (0.98–1.64) 1.25 (1.11–1.39)
4 (0.04–1.59) 1.15 (0.93–1.40) 0.75 (0.47–1.21) 0.94 (0.68–1.30)
0 (0.36–2.26) 0.91 (0.71–1.15) 1.25 (0.99–1.57) 1.04 (0.86–1.26)
9 (0.97–1.02) 0.98 (0.98–0.99) 0.96 (0.95–0.98) 0.98 (0.97–0.99)
3 (0.68–1.55) 1.05 (0.89–1.24) 1.16 (0.93–1.45) 1.11 (1.04–1.20)
4 (0.79–1.95) 1.15 (0.99–1.33) 0.91 (0.73–1.13) 1.01 (0.88–1.15)
0.95 (0.55–1.63) 2.09 (1.87–2.33) 1.12 (0.72–1.75)
1.74 (1.61–1.88) – 1.87 (1.73–2.01)
6 (1.35–4.12) 1.61 (1.30–1.99) 1.63 (1.09–2.44) 1.64 (1.46–1.83)
1 (1.47–4.26) 1.65 (1.33–2.03) 2.36 (1.65–3.38) 1.77 (1.47–2.14)
8 (1.04–3.06) 1.35 (1.12–1.63) 1.84 (1.33–2.56) 1.44 (1.24–1.67)
6 (0.43–1.03) 1.18 (1.01–1.37) 1.04 (0.70–1.53) 1.02 (0.80–1.32)
4 (0.33–1.23) 1.27 (1.09–1.47) 1.25 (0.61–2.59) 1.10 (0.96–1.27)
2 (1.69–3.89) 1.39 (1.20–1.62) 1.86 (1.53–2.25) 1.58 (1.35–1.86)
3 (1.52–2.98) 1.59 (1.39–1.81) 1.67 (1.36–2.04) 1.62 (1.52–1.74)
9 (0.61–1.62) 1.05 (0.87–1.27) 1.14 (0.82–1.59) 1.06 (1.00–1.12)
5 (0.98–2.14) 1.34 (1.16–1.55) 0.96 (0.69–1.33) 1.28 (1.15–1.43)
2 (0.64–2.35) 1.19 (1.00–1.41) 1.15 (0.88–1.52) 1.12 (1.01–1.25)
3 (0.91–1.95) 1.07 (0.92–1.24) 0.98 (0.79–1.22) 1.09 (0.99–1.19)
7 (0.76–1.81) 0.88 (0.74–1.05) 1.15 (0.92–1.45) 1.00 (0.86–1.18)
4 (0.85–1.82) 1.15 (0.99–1.33) 1.03 (0.82–1.28) 1.21 (1.03–1.42)
ing a p-value cut-off 6 0.25 are highlighted in bold. AEDs = anti-epileptic drugs.
del.
of those who had yearly seizures.
Table 5
Multivariable analysis results for factors associated with abnormal electroencephalographic features in people with active convulsive epilepsy across five African sites.
Features Agincourt Ifakara Iganga Kilifi Kintampo
RR (95% CI) RR (95% CI) RR (95%) RR (95%) RR (95%)
Perinatal abnormalities 1.88 (0.77–4.59) – – 1.14 (0.86–1.50) 1.39 (1.02–1.90)
Head injuries 2.00 (1.22–3.29) 1.54 (0.31–7.73) – – 1.33 (0.96–1.85)
Febrile status epilepticus – 3.52 (1.40–8.82) 0.88 (0.37–2.11) 1.14 (0.76–1.71) –
Neurological deficits 0.83 (0.29–2.37) 1.92 (1.09–3.39) 2.36 (1.25–4.45) 1.09 (0.87–4.06) 0.93 (0.64–1.36)
Cognitive impairments 2.00 (0.98–4.06) 0.84 (0.48–1.45) 1.19 (0.70–2.11) 1.54 (1.24–1.91) 1.05 (0.75–1.46)
AED use – 1.62 (1.08–2.42) 1.80 (1.06–3.05) 1.35 (1.13–1.61) –
RR = risk ratio; CI = confidence interval; AEDs-anti-epileptic drugs. Significant associations (p-value < 0.05) in each site are highlighted in bold. The non-highlighted asso-
ciations are not statistically significant and are provided where a risk factor was significant in at least one site to allow comparison across the five sites. Associations marked
with a dash (–) are for those variables that did not reach a cut-off for multivariable analysis.
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previous studies in the United States and United Kingdom
(Lomboroso, 1997; Kibuuka, 2011). In some people seizures may
rapidly generalize after a focal onset (Gwer et al., 2012), particu-
larly in focal symptomatic epilepsies, which are likely to be over-
represented in this group from sub-Saharan Africa compared with
unselected epilepsy populations with ACE from high-income coun-
tries. The correlation between focal features and focal neurological
deficits would support this conclusion. Most focal abnormalities
involved the temporal lobes. This may reflect the association
between temporal lobe pathology and poorly controlled prolonged
seizures particularly febrile status epilepticus, which is common in
Africa (Sadarangani et al., 2008; Kariuki et al., 2015b).4.3. Factors associated with EEG abnormalities across all sites
The frequency of abnormal EEGs in ACE was associated with
several epilepsy-related and clinical factors in a pooled analysis
of the five sites. Adverse perinatal events are a recognized cause
of epilepsy in Africa and can lead to persistent brain damage
(Ngugi et al., 2013), which may be associated with EEG changes
(Pressler et al., 2005). This may account for the significantly higher
frequency of EEG abnormalities in children, some of whommay die
before reaching adulthood. Focal seizures could be a marker of
localized brain damage by central nervous infections and injuries,
which may be reflected in both acute and chronic EEG abnormali-
ties (Crawley et al., 2001). AED use may be a surrogate marker of
severe epilepsy, hence its association with EEG abnormalities,
which are also related to seizure frequency (Kariuki et al., 2014).
The association between an abnormal EEG and cognitive impair-
ment confirms the negative impact which epilepsy may have on
intellectual function and behavior (Aldenkamp, 2006).4.4. Factors associated with EEG abnormalities within the sites
In the within site analysis, none of these factors was associated
with abnormal EEG across all the five sites. This highlights the
importance of site-specific preventative and management inter-
ventions for those with abnormal EEGs in ACE. For example, febrile
status epilepticus was important in Ifakara, a malaria endemic
area, where malaria may be the main cause for status epilepticus
(Sadarangani et al., 2008). Head injuries were an important associ-
ation in Agincourt, where most people with ACE were adults
(Kariuki et al., 2014), and indulge in violent or risk behavior that
can result in falls or accidents. These findings taken together sug-
gest that EEG abnormalities in ACE may be related to head trauma,
perinatal complications and infections, which could be preventable
by site specific interventions. EEGs may help identify those at risk
of cognitive impairments, which may be a consequence of ACE or
use of AEDs.4.5. Strengths and limitations
The large sample size, providing sufficient power to measure
associations between clinical groups is the major strength of the
study. Epilepsy cases were identified using a standard methodol-
ogy and one experienced clinical researcher (experienced in read-
ing EEGs) rated all EEGs following a standardized protocol. The
pooled analysis of factors associated with EEG abnormalities is reli-
able since we accounted for clustering within the sites. A limitation
is that we only performed a single routine EEG in each individual.
For logistic reasons we did not do serial or sleep EEGs recording,
which may have provided a higher diagnostic yield. The cognitive
impairment in this study should be interpreted carefully since
we assessed it by clinical evaluation of mental status rather than
by standardized neuropsychological tests.
4.6. Conclusion
EEG abnormalities are common in Africans with ACE, but the
prevalence and proportion of focal features vary according to site,
probably related to specific aetiological and clinical features of epi-
lepsy in these areas. The EEG features have clinical utility, particu-
larly in helping to identify focal epilepsies that can be further
evaluated with neuroimaging. EEG abnormalities are associated
with perinatal complications and severe epilepsy, and may predict
neurocognitive outcomes among those with ACE. Future studies
should apply EEG findings along with other clinical and neu-
roimaging features to improve the understanding and manage-
ment of epilepsy in Africa.
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